PRESS STATEMENTS12.01.2020 Pfizer and BioNTech Submitted Application for Conditional Marketing Authorization for COVID-19 Vaccine to the EMA11.20.2020 Pfizer Receives European Approval for Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim)11.16.2020 Pfizer Update On Our U.S. COVID-19 Vaccine Candidate Distribution Preparedness11.10.2020 Pfizer Statement on Geodon (ziprasidone) Trial Closure in the United States10.29.2020 New Report Identifies Need for More Effective Policy Responses and Investment to Prevent Strokes in Europe10.14.2020 Pfizer and BioNTech Announce New England Journal of Medicine Publication of Phase 1 Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-1909.30.2020 BioNTech and Pfizer Announce Nature Publication of German Phase 1/2 Study Data from mRNA-based Vaccine Candidate BNT162b1 Against SARS-CoV-208.17.2020 Pfizer Statement on Lyrica (Pregabalin) Patent Infringement in Japan08.12.2020 Pfizer and BioNTech Announce Publication of Peer-Reviewed Data from Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate, BNT162b1, Against SARS-CoV-2 in Nature08.06.2020 Pfizer signs on to The Hispanic Promise further strengthening its ties and commitment to Hispanics in the workplace08.05.2020 The Bristol-Myers Squibb-Pfizer Alliance is pleased with the U.S. District Court decision to uphold both the composition of matter (COM) patent (US 6,967,208) and formulation patent (US 9,326,945) covering Eliquis®.07.22.2020 Pfizer Shares Pre-Clinical Data Updates on COVID-19 Antiviral Research Program06.29.2020 Pfizer Statement on Facebook Advertising Boycott06.23.2020 NEW DATA ON THE BURDEN OF EMERGING S. PNEUMONIAE SEROTYPES PUBLISHED IN ISPPD 2020 ONLINE DIGITAL LIBRARY06.16.2020 Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Primary Endpoint in VERTIS CV Trial for Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease05.28.2020 Corning and Pfizer Announce Supply Agreement for Corning Valor® Glass Packaging05.01.2020 Pfizer Receives Positive CHMP Opinion for DAURISMO® (glasdegib) for Certain Adult Patients with Newly Diagnosed or Secondary Acute Myeloid Leukemia (AML)03.02.2020 Pfizer Provides Comment on COVID-19 White House Meeting01.23.2020 Pfizer Brings Three New Biosimilars to U.S. Patients at Substantial Discounts11.15.2019 Pfizer Announces CHMP Opinion for XELJANZ® (tofacitinib) in the European Union Related to Ongoing Review of the ProductPagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6Next pageNext ›Last pageLast »Press Release ArchivePress StatementsPodcastsThe Antigen PodcastThe Antigen Podcast Season 1The Antigen Podcast Episode 1: Vaccines 101The Antigen Podcast Episode 2: The History of VaccinesThe Antigen Podcast Episode 3: Global Perspectives, Barriers & SolutionsThe Antigen Podcast Episode 4: Vaccine Hesitancy Part 1The Antigen Podcast Episode 5: Vaccine Hesitancy Part 2The Antigen Podcast Episode 6: Vaccine Politics, Policy & AdvocacyThe Antigen Podcast Episode 7: Innovations in the Vaccine LandscapeThe Antigen Podcast Episode 8: What's Next?The Antigen Podcast Season 2The Antigen Podcast Episode 1: #COVID19 Looking Back to Look ForwardThe Antigen Podcast Episode 2: #COVID19 What Do We Do in the Meantime?The Antigen Podcast Episode 3: #COVID19 The Quest for a VaccineThe Antigen Podcast Episode 4: #COVID19 Teamwork Makes the Dream WorkGet Science PodcastDiverse Perspectives Podcastmenopause: unmutedContact Media RelationsPress Kits & DownloadsCompany Press KitPfizer Oncology Press KitPSA NarrativeRA NarRAtiveRare Disease Gene Therapy Press KitTTR-Amyloidosis Press KitUC NarrativeOnline Pfizer Press KitCompany Press KitView the Pfizer Company Press KitPress StatementsView Pfizer's latest press statements Related ArticlesYour HealthIn Her Words: Jacklyn’s Life With Ulcerative ColitisYour HealthFeeling Sick? Use this Symptom Checker for Common Fall and…Your HealthCOVID-19 Vaccine U.S. Distribution Fact SheetOur ScienceOur COVID-19 Vaccine Study – What’s Next?Our ScienceAlbert Bourla Discusses Our FDA SubmissionYour HealthmRNA – Technology at the Forefront During A Global PandemicYour HealthWhy Your Family Health History MattersYour HealthWhy You Need Your Workout Now More Than EverOur PurposePartnering for Sustainable Solutions: Combatting the Deadly…Your HealthChronic Stress and How to Manage ItOur PeopleCelebrating Our Veterans: A Salute to Their ServiceOur ScienceAn Open Letter to COVID-19 Vaccine Trial Participants from…Our ScienceUPDATE: ALBERT BOURLA DISCUSSES COVID-19 VACCINE EFFICACY RESULTSOur PeopleGetting to Know Kristin Tompkins; A Day In The Life of a Pfizer…Your HealthShedding Light on Seasonal Affective DisorderYour HealthWhat is Ankylosing Spondylitis?Your HealthUnderstanding the Differences and Similarities Between the Flu…Our ScienceAn Open Letter from Pfizer Chairman and CEO Albert BourlaOur PeopleYo Me Cuido (I Take Care of Myself)Our PeopleDiverse PerspectivesOur PurposeThe Pfizer Foundation Invests in Community-Based Solutions to…ShowHide
